Summary
Gamma-hydroxybutyrate administered in anesthetic doses produces a time dependent increase in the levels of rat brain acetylcholine. A maximal increase in whole brain and subcortical levels of acetylcholine is observed about 15 min after administration of the lactone form of the drug. A similar GHB-induced increase in acetylcholine is observed in the striatum and a 75% increase in the hippocampus 15 min after administration of the drug. A good temporal correlation was not obtained between the increase in acetylcholine and the depth of anesthesia produced by the drug. Gamma-hydroxybutyrate did not cause a significant change in the striatal or hippocampal levels of choline. Possible mechanisms involved in the production of this increase in acetylcholine are discussed.
Similar content being viewed by others
References
Aghajanian, G. K., Roth, R. H.: γ-Hydroxybutyrate-induced increase in brain dopamine: Localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131–137 (1970)
Agid, Y., Guyunet, P., Javoy, F., Beaujouan, J. C., Glowinski, J.: Specific aspects of antagonists and agonists of dopamine receptors on acetylcholine turnover in the neostriatum. J. Pharmacol. 5, Suppl. 1, 59–69 (1974)
Andén, N.-E., Bedard, P., Fuxe, K., Ungerstedt, U.: Early and selective increase in brain dopamine after axotomy. Experientia (Basel) 28, 300–302 (1972)
Andén, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gamma-aminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89 (1973)
Bonta, I. L., De Vos, C. J., Grijsen, H., Hillen, F. C., Noach, E. L., Sim, A. W.: 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966): A new GABA-like compound with potential use in extrapyramidal disease. Brit. J. Pharmacol. 43, 514–535 (1971)
Campbell, L. B., Jenden, D. J.: Gas chromatographic evaluation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain. J. Neurochem. 17, 1697–1699 (1970)
Cheney, D. L., Racagni, G., Zsilla, G., Costa, E.: Differences in action of various drugs on striatal acetylcholine and choline content in rats killed by decapitation or microwave radiation. J. Pharm. Pharmacol. 28, 75–77 (1976)
Crossland, J., Merrick, A. J.: The effect of anesthesia on the acetylcholine content of the brain. J. Physiol. (Lond.) 125, 56–66 (1954)
Fonnum, F.: Recent developments in biochemical investigations of cholinergic transmission. Brain Res. 62, 497–507 (1973)
Gessa, G. L., Crabai, F., Vargiu, L., Spano, P. F.: Selective increase of brain dopamine induced by γ-hydroxybutyrate: study of the mechanism of action. J. Neurochem. 15, 377–381 (1968)
Gessa, G. L., Spano, P. F., Vargiu, L., Crabai, R., Tagliamonte, A., Mammeli, L.: Effect of 1,4-butanediol and other butyric acid congeners or brain catecholamines. Life Sci. 7, 289–298 (1968)
Gessa, G. L., Vargiu, L., Crabai, F., Boero, C. C., Caboni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5, 1921–1930 (1966)
Giarman, N. J., Pepeu, G.: Drug induced changes in brain acetylcholine. Brit. J. Pharmacol. 19, 226–234 (1962)
Giarman, N. J., Schmidt, K. F.: Some neurochemical aspects of the depressant action of butyrolactone on the central nervous system. Brit. J. Pharmacol. 20, 563–568 (1963)
Glowinski, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain I. J. Neurochem. 13, 655–669 (1966)
Guyenet, P., Lefrense, P., Rossier, J., Beaujouan, J. C., Glowinski, J.: Effect of sodium, hemicholinium-3, and antiparkinson drugs on [14C]-acetylcholine synthesis and [3H]-choline uptake in rat striatal synaptosomes. Brain Res. 62, 523–529 (1973)
Haga, T., Noda, H.: Choline uptake systems of rat brain synaptosomes. Biochim. biophys. Acta (Amst.) 291, 564–575 (1973)
Hanin, I., Massarelli, R., Costa, E.: An approach to the in vivo study of acetylcholine turnover in rat salivary gland by ratio gas chromatography. J. Pharmacol. exp. Ther. 181, 10–18 (1972)
Hillen, F. C., Noach, E. L.: The influence of 1-hydroxy-3-aminopyrolidone-2 (HA-966) on dopamine metabolism in the rat corpus striatum. Europ. J. Pharmacol. 16, 222–229 (1971)
Jenden, D. J., Hanin, I., Lamb, S. I.: Gas chromatographic microestimation of acetylcholine and related compounds. Analyt. Chem. 40, 125–128 (1968)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972)
Konig, J. F. R., Klippel, R. A.: The rat brain. Baltimore: Williams and Wilkins, 1967
Krnjevic, K.: Chemical nature of synaptic transmission in vertebrates. Physiol. Rev. 54, 418–540 (1974)
Ladinsky, H., Consolo, S., Garattini, S.: Increase in striatal acetylcholine levels in vivo by piribedil. A new dopamine receptor stimulant. Life Sci. 14, 1251–1260 (1974)
Langer, S. Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23, 1793–1800 (1974)
Maxwell, R., Roth, R. H.: The conversion of 1,4-butanediol to hydroxybutyric acid in rat brain and in peripheral tissue. Biochem. Pharmacol. 21, 1521 (1972)
McCaman, M. W., Tomey, L. R., McCaman, R. E.: Radiomimetric assay of acetylcholinesterase activity in submicrogram amount of tissue. Life Sci. 7, 233–244 (1968)
McGeer, P. L., Grewaal, D. S., McGeer, E. G.: Influence of noncholinergic drugs on rat striatal acetylcholine levels. Brain Res. 80, 211–217 (1974)
Morgenroth, V. H., III, Walters, J. R., Roth, R. H.: Dopaminergic neurons: alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem. Pharmacol. (in press) (1976)
Mulder, A. H., Yamamura, H. I., Kuhar, M. J., Snyder, S. H.: Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake. Brain Res. 70, 372–376 (1974)
Pilar, G.: Effect of ACh on pre-and post-synaptic elements of avian ciliary ganglion synapses. Fed. Proc. 28, 670 (1969)
Potenpska, A., Gradkowska, M., Oderfeld-Nowak, B.: Early changes in acetylcholine pools in the hippocampus of the rat brain after septal lesions. J. Neurochem. 24, 787–789 (1975)
Richter, D., Crossland, J.: Variation in acetylcholine content of the brain with physiological state. Amer. J. Physiol. 159, 247–255 (1949)
Rommelspacher, H., Goldberg, A. M., Kuhar, M. J.: Action of hemicholinium-3 on cholinergic nerve terminals after alteration of neuronal impulse flow. Neuropharmacology 13, 1015–1023 (1974)
Roth, R. H., Giarman, N. J.: γ-Butyrolacetone and γ-hydroxybutyric acid. I. Distribution and metabolism. Biochem. Pharmacol. 15, 1333–1348 (1966)
Roth, R. H., Surh, Y.: Mechanism of the gamma-hydroxybutyrate induced increase in brain dopamine and its relationship to “sleep”. Biochem. Pharmacol. 19, 3001–3012 (1970)
Roth, R. H., Walters, J. R., Aghajanian, G. K.: Effect of impulse flow on the release and synthesis of DA in the rat striatum. In: Frontiers in catecholamine research (E. Usdin and S. H. Snyder, eds.), pp. 567–574. New York: Pergamon Press Inc. 1973
Roth, R. H., Walters, J. R., Morgenroth, V. H. III: Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons. Neurospychopharmacology of monoamines and their regulatory enzymes (E. Usdin, ed.), pp. 369–384. New York: Raven Press 1974
Sethy, V. H., Kuhar, M. J., Roth, R. H., Van Woert, M. H., Aghajanian, G. K.: Cholinergic neurons: effect of acute septal lesions on acetylcholine and choline content of rat hippocampus. Brain Res. 55, 481–484 (1973)
Sethy, V. H., Van Woert, M. H.: Effect of l-Dopa on brain acetylcholine and choline in rats. Neuropharmacology 12, 27–31 (1973)
Sethy, V. H., Van Woert, M. H.: Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists. Res. Commun. chem. Path. Pharmacol. 8, 13–28 (1974)
Simon, J. R., Kuhar, M. J.: Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals. Nature (Lond.) 255, 162–163 (1975)
Spano, P. F., Tagliamonte, A., Tagliamonte, P., Gessa, G. L.: Increase of dopamine synthesis induced by gamma-hydroxybutyric acid. Riv. Farmacol. Ter. I, 3–11 (1970)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse with gammahydroxybutyric acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–362 (1973)
Tobias, J. M., Lipton, M. A., Lepinat, A.: Effect of anesthetics and convulsants on brain acetylcholine content. Proc. Soc. exp. Biol. (N. Y.) 61, 51–54 (1946)
Walters, J. R., Aghajanian, G. K., Roth, R. H.: Dopaminergic neurons: inhibition of firing by γ-hydroxybutyrate. Proc. Fifth Int. Cong. Pharmacol. p. 246 (1972)
Walters, J. R., Roth, R. H.: Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem. Pharmacol. 21, 2111–2121 (1972)
Walters, J. R., Roth, R. H.: Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharmacol. exp. Ther. 191, 82–91 (1974)
Walters, J. R., Roth, R. H.: Gamma-hydroxybutyrate: Considerations of endogenous role and therapeutic potential. In: Neurotransmitters and hypotheses of psychiatric disorder (E. Usdin, D. Hamburg, and J. D. Barchas, eds.). New York: Oxford University Press (in press 1976)
Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of gammahydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J. Pharmacol. exp. Ther. 186, 630–639 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sethy, V.H., Roth, R.H., Walters, J.R. et al. Effect of anesthetic doses of γ-hydroxybutyrate on the acetylcholine content of rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 9–14 (1976). https://doi.org/10.1007/BF00509765
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00509765